Episode 154: New Drug Approvals for Metastatic Castration-Sensitive Prostate Cancer

<p>Andrew Ruplin, PharmD, clinical instructor and oncology clinical pharmacist at Seattle Cancer Care Alliance and the University of Washington in Seattle, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss new drug approvals for metastatic castration-sensitive prostate cancer. Astellas provided support for this podcast episode through an educational grant.</p> <p>Music Credit: "<a href="http://www.incompetech.com/">Fireflies and Stardust</a>" by Kevin MacLeod</p> <p>Licensed under Creative Commons by Attribution 3.0</p> <p>Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by May 7, 2023. The planners and faculty for this episode have no conflicts to disclose, and the episode has no commercial support. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation.</p> <p><strong>Episode Notes</strong></p> <p>Check out these resources from today’s episode:</p> <ul> <li><a href= "https://courses.ons.org/diweb/gateway/init/1/f/catalog*2Fitem*2Feid*2FP413"> Complete this evaluation for free NCPD</a>.</li> <li><a href= "https://www.ons.org/podcasts/episode-149-health-disparities-and-barriers-metastatic-castration-sensitive-prostate"> <em>Oncology Nursing Podcast</em> Episode 149: Health Disparities and Barriers in Metastatic Castration-Sensitive Prostate Cancer</a></li> <li><em>ONS Voice</em> articles: FDA approvals for <a href= "https://voice.ons.org/news-and-views/fda-approves-abiraterone-acetate-with-prednisone-for-high-risk-metastatic-cspc"> abiraterone acetate</a>, <a href= "https://voice.ons.org/news-and-views/fda-approves-apalutamide-for-metastatic-castration-sensitive-prostate-cancer"> apalutamide</a>, <a href= "https://voice.ons.org/news-and-views/fda-approves-enzalutamide-for-metastatic-castration-sensitive-prostate-cancer"> enzalutamide</a>, <a href= "https://voice.ons.org/news-and-views/fda-approves-olaparib-for-